News

Corneal arcus has been associated with higher intraocular pressure (IOP) and lower central corneal thickness (CCT), according to a recent study.

i-Optics has announced the successful closure of its third financing round with an investment of €4.2 million, which will enable the company to launch its first product for 2011 early

The FDA has cleared an age-adjusted retinal nerve fibre layer thickness normative database for a proprietary ocular coherence tomography (OCT) device, Spectralis (Heidelberg Engineering).

The ACI 7000 corneal inlay has shown safety and efficacy over a two-year study period in presbyopia patients, according to a study published in the Journal of Refractive Surgery.

Curcumin-based treatment Norflo, has been shown to alleviate the symptoms of anterior uveitis in a recent study published in Clinical Ophthalmology, indicating a potential role for the anti-inflammatory treatment curcumin in eye inflammatory and degenerative conditions.

Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its therapy Lucentis for the treatment of patients with diabetic macular oedema (DME).

BiCOM showcased its Diaton tonometer at this year's AAO/MEACO meeting. The pen-like, handheld, portable device can measure eye pressure through the patient's eyelid and over the sclera.

RXi and EyeGate have announced a collaboration focused on non-invasive ocular delivery of RNAi therapeutics. Both companies will contribute technology, expertise and resources to the partnership.

Researchers have found that giving patients a dual therapy of bimatoprost and a beta-blocker is an effective method of lowering intraocular blood pressure (IOP) in patients with open-angle glaucoma.